People living with cancer and the healthcare professionals caring for them are the winners from a $7 million investment, NSW Regional Health Partners announced on Friday.
Four Hunter research teams have secured more than $6 million in funding through the Australian Government's Medical Research Future Fund, bolstering HMRI and the University of Newcastle's commitment to better, healthier living within our regions and beyond.
Lots of curiosity and questions surround COVID-19 and the COVID-19 vaccines.
So what's fact and what is fiction. We put the call out on our social media channels for your COVID questions and had them answered by some of our leading experts in this space.
Associate Professor Narelle Eather knows the pressure on teachers to cover the curriculum while keeping kids engaged and active. Before teaching at the University of Newcastle and becoming a HMRI Physical Activity Researcher she taught primary and secondary school students.
ImmVirX Pty Ltd has announced the successful completion of $22 million in fundraising, which will go towards the first human studies of its new cancer treatment. ImmVirX is a biotechnology company based at the Hunter Medical Research Institute (HMRI*) and is supported by the University of Newcastle Research Associates (TUNRA).